Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,400
Total Claims
$1.1M
Drug Cost
477
Beneficiaries
$2,245
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-59%
Opioid rate vs peers
0.9% vs 2.2% avg
+59%
Cost per patient vs peers
$2,245 vs $1,411 avg
+37%
Brand preference vs peers
14.6% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.9%
Opioid Rate
86
Opioid Claims
$985
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,351 claims · $934K
Generic: 7,895 claims · $129K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 96 | $120K |
| Semaglutide | 95 | $108K |
| Insulin Glargine,hum.Rec.Anlog | 77 | $63K |
| Fluticasone/Umeclidin/Vilanter | 58 | $53K |
| Linaclotide | 46 | $52K |
| Apixaban | 52 | $47K |
| Dulaglutide | 23 | $38K |
| Sitagliptin Phosphate | 44 | $35K |
| Linagliptin | 31 | $28K |
| Dapagliflozin Propanediol | 24 | $23K |
| Semaglutide | 16 | $20K |
| Mirabegron | 20 | $15K |
| Ipratropium/Albuterol Sulfate | 14 | $13K |
| Insulin Detemir | 12 | $12K |
| Fluticasone/Vilanterol | 15 | $11K |
Prescribing Profile
Patient Profile
73
Avg Age
74%
Female
1.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About